Swedish fintech giant Klarna has officially filed for its long-anticipated U.S. IPO, aiming to raise over $1 billion at a valuation exceeding $15 billion, according to reports. The buy now, pay later (BNPL) pioneer saw a 24% surge in revenue, reaching $2.81 billion in 2024, while posting a $21 million profit, a sharp turnaround from its $244 million loss the previous year.
Klarna's IPO arrives at a pivotal time as investor appetite for fintech listings rebounds. While the sector cooled due to rising interest rates, companies like Klarna, Affirm, and Block are now capitalizing on renewed demand for alternative payment solutions. The BNPL market is projected to surpass $160 billion by 2032, with major retailers like Walmart, Target, and Amazon integrating these services to attract younger, credit-conscious shoppers.
Despite past IPO delays, Klarna’s move signals growing confidence in fintech valuations. Its rapid ascent—from a $5.5 billion valuation in 2020 to $46.5 billion in 2021—was fueled by major backers like Sequoia Capital. However, it later raised funds at a reduced $6.7 billion valuation. Klarna now joins Stripe and Chime, both eyeing IPOs, in testing market sentiment for high-growth fintech firms.
The company, operating in 26 countries with 93 million active users, has partnered with global brands like Nike, Sephora, and Airbnb. Trading under "KLAR" on the NYSE, Klarna has tapped Goldman Sachs, J.P. Morgan, and Morgan Stanley as lead underwriters. While regulatory scrutiny and market volatility pose challenges, Klarna’s IPO could reignite investor enthusiasm for fintech stocks.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Washington Post Publisher Will Lewis Steps Down After Layoffs 



